Cargando…
Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2- and NCK-interacting Kinase Inhibitor
TRAF2- and NCK-interacting kinase (TNIK) represents one of the crucial targets for Wnt-activated colorectal cancer. In this study, we curated two datasets and conducted a comprehensive modeling study to explore novel TNIK inhibitors with desirable biopharmaceutical properties. With Dataset I, we der...
Autores principales: | Tan, Zhi, Chen, Lu, Zhang, Shuxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030704/ https://www.ncbi.nlm.nih.gov/pubmed/27650168 http://dx.doi.org/10.1038/srep33534 |
Ejemplares similares
-
Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma
por: Sekita, Tetsuya, et al.
Publicado: (2020) -
Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK)
por: Ma, Lushun, et al.
Publicado: (2022) -
Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer
por: Takahashi, Hidenori, et al.
Publicado: (2015) -
Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846
por: Sugano, Teppei, et al.
Publicado: (2020) -
Deficiency of germinal center kinase TRAF2 and NCK-interacting kinase (TNIK) in B cells does not affect atherosclerosis
por: van Os, Bram W., et al.
Publicado: (2023)